Abstract

Rhodococcus fascians BD8, isolated from Arctic soil, was found to produce biosurfactant when grown on n-hexadecane as the sole carbon source. The glycolipid product was identified as the trehalose lipid with a molecular mass of 848 g mol−1. The purified biosurfactant reduced the surface tension of water from 72 to 34 mN m−1. The critical micelle concentration of trehalose lipid was 0.140 mg mL−1. To examine its potential for biomedical applications, the antimicrobial and antiadhesive activity of the biosurfactant was evaluated against several pathogenic microorganisms. Trehalose lipid showed antimicrobial activity against resistant pathogens. The largest antimicrobial activities of trehalose lipid were observed against Vibrio harveyi and Proteus vulgaris. The highest concentration tested (0.5 mg mL−1) caused a partial (11–34%) inhibition of other Gram-positive and Gram-negative bacteria and 30% inhibition of Candida albicans growth. The trehalose lipid also showed significant antiadhesive properties against all of the tested microorganisms to polystyrene surface and silicone urethral catheters. The biosurfactant showed 95 and 70% antiadhesive activity against C. albicans and Escherichia coli, respectively. Finally, the role and application of trehalose lipid as an antiadhesive compound was investigated by the modification of the polystyrene and silicone surfaces. The intermolecular interaction energy calculations were performed for investigated complexes at the density functional level of theory. The results indicate that the presence of aromatic moieties can be substantial in the stabilization of trehalose lipid-surface complexes. The antimicrobial and antiadhesive activities of trehalose lipid make them promising alternatives to synthetic surfactants in a wide range of medical applications. Based on our findings, we propose that, because of its ability to inhibit microbial colonization of polystyrene and silicone surfaces, trehalose lipid can be used as a surface coating agent.

Highlights

  • Drug resistance of bacterial and fungal infections is increasing worldwide

  • The antimicrobial and antiadhesive activities of the trehalose lipid were tested on the following strains of microorganisms: (1) Gram-positive bacteria Enterococcus hirae ATCC 10542, Enterococcus faecalis JA/3, E. faecalis ATCC 29212, and Staphylococcus epidermidis KCTC 1917; (2) Gram-negative bacteria E. coli 17-2, E. coli ATCC 10536, E. coli ATCC 25922, Proteus vulgaris ATCC 27973, Proteus mirabilis ATCC 21100, and Vibrio harveyi ATCC 14126; (3) yeasts C. albicans ATCC 10231 and C. albicans SC5314

  • We show that the trehalose lipid synthesized by the BD8 strain of R. fascians is an attractive compound for the control and prevention of infection and might be employed in a diverse range of antimicrobial applications

Read more

Summary

Introduction

Drug resistance of bacterial and fungal infections is increasing worldwide. Microbial biofilm-associated infections are frequently refractory to conventional therapy because of resistance to antimicrobial agents (Sanchez et al, 2013; Malone et al, 2017). 80% of hospital-acquired infections are associated with the use of indwelling urinary catheters, where Escherichia coli and Candida albicans are among the most prevalent pathogens in urinary tract infections (Russo and Johnson, 2003; Patil et al, 2015). Biofilm-associated bacterial and fungal infections show uniform resistance to a wide spectrum of the currently available conventional agents, which implies that antimicrobial drugs against targeted biofilm-associated infections are needed. Many laboratories are synthesizing or isolating new compounds that prevent the formation of biofilms or cause their elimination

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call